arborcandins (Sankyo)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namearborcandins (Sankyo)
Drug Alias Namearborcandin Aarborcandin Barborcandin Darborcandin Farborcandin C +[6] 
ClassificationSmall moleculesNatural product/Extract
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsMycoses

Other Information

ATC CodeN/A
Related LinksN/A